These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5091785)

  • 1. [Mesothelioma of the peritoneum].
    Jacyna-Onyszkiewicz T; Panecka A
    Pol Przegl Chir; 1971 May; 43(5):737-40. PubMed ID: 5091785
    [No Abstract]   [Full Text] [Related]  

  • 2. Continued uncertainty regarding hyperthermic intraperitoneal chemotherapy in malignant peritoneal mesothelioma.
    Markman M
    J Clin Oncol; 2010 Aug; 28(24):e418; author reply e419. PubMed ID: 20566999
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating CA125 and diffuse malignant peritoneal mesothelioma.
    Baratti D; Kusamura S; Deraco M
    Eur J Surg Oncol; 2009 Nov; 35(11):1198-9. PubMed ID: 19423265
    [No Abstract]   [Full Text] [Related]  

  • 4. [Short-term intraperitoneal infusion of cisplatin and OK-432 for a case of malignant mesothelioma of the peritoneum].
    Kuwabara K; Ishida H; Ohsawa T; Nakata H; Murata N; Hashimoto D; Adachi A; Itoyama S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2333-5. PubMed ID: 12484067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
    Sugarbaker PH
    J Surg Oncol; 2005 Nov; 92(2):142-6. PubMed ID: 16231365
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
    Chua TC; Yan TD; Morris DL
    J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
    Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
    In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
    Yano H; Moran BJ; Cecil TD; Murphy EM
    Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneum as the first-line of defense in carcinomatosis.
    Sugarbaker PH
    J Surg Oncol; 2007 Feb; 95(2):93-6. PubMed ID: 17262739
    [No Abstract]   [Full Text] [Related]  

  • 10. [Malignant mesothelioma of the peritoneum. Case report].
    Richter B; Richter P; Buchholz K
    Zentralbl Gynakol; 1983; 105(9):598-601. PubMed ID: 6880476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Updated treatment of peritoneal carcinomas: a review].
    Deraco M; Laterza B; Kusamura S; Baratti D
    Minerva Chir; 2007 Dec; 62(6):459-76. PubMed ID: 18091656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases.
    Yan TD; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
    Ann Surg Oncol; 2007 Feb; 14(2):515-25. PubMed ID: 17031722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sudden increase in abdominal circumference in a young man].
    Slawik HR; Wienbeck M; Wagner T; Lindemann F; Hassel J
    Internist (Berl); 1991 Aug; 32(8):492-4. PubMed ID: 1938271
    [No Abstract]   [Full Text] [Related]  

  • 14. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
    Deraco M; Casali P; Inglese MG; Baratti D; Pennacchioli E; Bertulli R; Kusamura S
    J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of ascities decrease in malignant peritoneal mesothelioma by weekly intra-peritoneal administration of cisplatin and paclitaxel].
    Ami K; Nagahama T; Andou M; Nawa K; Ganno H; Ohbu M; Kimu K; Ito T; Yamauchi A; Ichikawa S; Kobo T; Takaba E
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1709-11. PubMed ID: 16315916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin.
    Van der Speeten K; Stuart OA; Mahteme H; Sugarbaker PH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):799-805. PubMed ID: 18654746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus statement on peritoneal mesothelioma.
    Deraco M; Bartlett D; Kusamura S; Baratti D
    J Surg Oncol; 2008 Sep; 98(4):268-72. PubMed ID: 18726890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of 41 patients with malignant peritoneal mesothelioma].
    Zhang ZG; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):631-3. PubMed ID: 15634530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
    Ma GY; Bartlett DL; Reed E; Figg WD; Lush RM; Lee KB; Libutti SK; Alexander HR
    Cancer J Sci Am; 1997; 3(3):174-9. PubMed ID: 9161783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Building on a consensus.
    Sugarbaker PH
    J Surg Oncol; 2008 Sep; 98(4):215-6. PubMed ID: 18726906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.